Dosing chart / Healing & recovery
TB-500 vs GHK-Cu
Dose, schedule, route and approval status side by side.
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.
| TB-500 | GHK-Cu | |
|---|---|---|
| Status | Not approved | Not approved |
| Also known as | thymosin beta-4 fragment | copper peptide |
| Typical dose | 2–5 mg per week | 1–2 mg |
| How often | Twice weekly | Daily |
| Schedule | Usually split into two injections a week for 4–6 weeks, then about 2 mg every 1–2 weeks. | Once daily by injection. Also widely used in skin creams. |
| Daily equivalent | ≈ 0.29–0.71 mg/day | 1–2 mg/day |
| Route | Subcutaneous | Subcutaneous or topical |
| Duration | 4–6 week loading phase reported | 4–6 weeks reported |
| Notes | No human efficacy trials for the fragment. Doses are community-reported. | Human evidence is for topical cosmetic use. Injected doses are community-reported and often sting. |
This page sets the two chart entries next to each other. It does not say which is better or whether either is right for you. Read member experiences on the TB-500 and GHK-Cu pages.
Advertisement